News & Trends - Pharmaceuticals

Mental health pharmacy trial on track to commence

Health Industry Hub | August 3, 2020 |
[Total: 1    Average: 4/5]

Pharma News: The Pharmacy Guild of Australia (Guild), Pharmaceutical Society of Australia (PSA), Griffith University (GU) and The University of Sydney (USYD) are pleased to announce that The Bridging the Gap between Physical and Mental Illness in Community Pharmacy (PharMIbridge) trial is set to commence in a few months’ time.

This study, co-led by highly respected pharmacy and mental health researchers Professor Amanda Wheeler (GU) and Dr Claire O’Reilly (USYD), focuses on individualised medicine support, adherence and mental and physical wellbeing for people living with severe and persistent mental illness such as schizophrenia, bipolar and severe depression.

The National President of the Pharmacy Guild, George Tambassis, said community pharmacists were playing an increasingly important role in the area of mental health.

“As the most accessible of all health professionals, community pharmacists are often the first people mental health patients turn to for help and advice.  Many pharmacists have undergone additional training to help them identify patients who may be suffering mental illness.

“Pharmacists also are critical in helping patients adhere to their medicine regimens to ensure they  get best possible outcomes from the medicines they have been prescribed.

“This project is an exciting and important initiative to broaden the role of pharmacists in helping patients with mental illness.”

Pharmaceutical Society of Australia National President Associate Professor Chris Freeman said as medicines experts, pharmacists play a vital role in treating mental illness in the community.

“Medicines are an important component of treatment for people living with mental illness which is why pharmacists, as medicines experts, have a critical role to play, however that should not limit our role,” he said.

“Pharmacists serve as a critical element in the healthcare team, working with patients to manage their conditions, often as a conduit to other services, an advocate for the person, or to lend a compassionate ear.”

The RCT will be conducted in four study regions: Hunter New England and Northern Sydney regions in NSW, Gippsland region in Victoria, and ACT. Participating community pharmacies will be remunerated to support training attendance and to deliver either the PharMIbridge (intervention) or study funded MedsCheck (comparator) service.


About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

News & Trends - Medical Technology

MedTech News - Sustained COVID-19 impact on cancer services and procedures

Sustained COVID-19 impact on cancer services and procedures

Health Industry Hub | January 15, 2021 |

MedTech News: Cancer Australia has released the latest in a series of reports analysing for the first time the significance […]

More


News & Trends - Medical Technology

MedTech News - Healthscope hospital leading in high-tech medical surgery

Healthscope hospital leading in high-tech medical surgery

Health Industry Hub | January 15, 2021 |

MedTech News: Healthscope’s Knox Private Hospital recently celebrated two key milestones, underscoring its reputation as a leading proponent of high-tech […]

More


News & Trends - Pharmaceuticals

Pharma News - Experts comment on AstraZeneca vaccine efficacy concerns

Experts comment on AstraZeneca vaccine efficacy concerns

Health Industry Hub | January 15, 2021 |

Pharma News: In light of the comments made regarding AstraZeneca’s COVID-19 vaccine efficacy by the Australian and New Zealand Society […]

More


Communication

Communication Pharma Biotech Medtech - Secrets of persuasion to influence anyone

Secrets of persuasion to influence anyone

Health Industry Hub | January 15, 2021 |

To understand the art of persuasion, you can turn to cognitive science for guidance in dealing with the unconscious mind. […]

More